Predictive Oncology granted Nasdaq extension through Dec 8, 2025 to regain listing compliance

Axe Compute Inc.

Nasdaq Hearing Panel extended continued listing deadline to December 8, 2025.
Company must demonstrate compliance with $2.5M stockholders' equity and $1.00 bid price requirements.
Hearing held July 17, 2025; extension granted July 23, 2025.
Previously disclosed bid price deficiency (below $1 for 30 consecutive business days) also cited.
Company pursuing actions but no assurance of regaining compliance; delisting risk remains.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.